sanuwave
-
Financial
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results
Q3 2024 revenues were $9.4 million, up 89% from Q3 2023. This was an all-time quarterly record for the Company.…
Read More » -
Financial
SANUWAVE Health Announces 1-For-375 Reverse Stock Split
Common Stock Will Begin Trading on a Split-adjusted Basis on October 18, 2024 EDEN PRAIRIE, Minn., Oct. 16, 2024 (GLOBE…
Read More » -
Financial
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results
Q2 2024 revenues were $7.2 million, up 53% from Q2 2023. This was an all-time quarterly record for the Company.…
Read More » -
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31,…
Read More » -
Biologics
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
Sorensen brings strong finance, forecasting, analysis, and capital markets experience as well as abilities in software, process automation, and human…
Read More » -
Financial
SANUWAVE Announces Record Q4 and FY2023 Revenue
Q4 2023 revenues were a record $7.0 million, up 27% from Q4 2022 FY 2023 revenues were a record $20.4…
Read More » -
Financial
SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders
At a special meeting of stockholders on February 21, 2024, SANUWAVE stockholders approved the business combination with SEP Acquisition Corp.…
Read More » -
Financial
SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)
EDEN PRAIRIE, MN, Jan. 22, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider…
Read More » -
Financial
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023
SANUWAVE is pleased to announce preliminary revenues of $6.6 million to $6.8 million for the fourth quarter ended December 31,…
Read More » -
Financial
SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results
EDEN PRAIRIE, MN, Nov. 08, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation…
Read More » -
Financial
SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023
SANUWAVE is Pleased to Announce Preliminary Revenues of $4.7 Million to $4.9 Million for the Third Quarter Ended September 30,…
Read More » -
Financial
SANUWAVE Announces Q2 2023 Financial Results
EDEN PRAIRIE, MN, Aug. 11, 2023 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading…
Read More » -
Biologics
SANUWAVE Signs Distribution Agreement With Pacific Medical, Inc.
Pacific Medical to bring its sales force of over 215 dedicated representatives covering seven western states to the SANUWAVE UltraMist…
Read More » -
Biologics
SANUWAVE Health Appoints Industry Veteran Andrew Walko as President
Walko brings 17 years of Manufacturing, Production, Operations, and Logistics Experience, most recently as President of Biomerics, where he led…
Read More » -
Financial
SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended June 30, 2023
SANUWAVE is pleased to announce preliminary revenues of $4.5 million to $4.7 million for Q2 ended June 30, 2023 Results…
Read More »